Growth Metrics

Canton Strategic Holdings (CNTN) Shares Outstanding (Weighted Average) (2020 - 2026)

Canton Strategic Holdings posted quarterly Shares Outstanding (Weighted Average) of $207.7 million for Q1 2026, up 41541081.0% year-on-year from N/an in Q1 2025, and up 359956.69% on a QoQ basis from $57687.0 in Q4 2025.

Canton Strategic Holdings (CNTN) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $207.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 41541081.0% year-over-year to $207.7 million; the trailing twelve-month figure through Mar 2026 stood at $207.7 million (up 41541081.0% YoY), and the FY2025 full-year result was $57687.0, down 88.25% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $207.7 million, up from $57687.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $207.7 million in Q1 2026 and bottomed at $500.0 in Q1 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $187500.0 (2022), against an average of $13.3 million.
  • The widest annual swing landed in 2025, when Shares Outstanding (Weighted Average) tumbled 99.94%; it then jumped 41541081.0% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $452686.0 in 2022, then slumped by 80.76% to $87079.0 in 2023, then jumped by 1388.64% to $1.3 million in 2024, then sank by 95.55% to $57687.0 in 2025, then jumped by 359956.69% to $207.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $207.7 million (Q1 2026), $57687.0 (Q4 2025), and $274897.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 177,333.76 Bn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 185,491.37 Bn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 55.66 Bn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 132.89 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn - 207.71 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 207.71 Mn
Dec 31, 2025 57,687.00
Sep 30, 2025 274,897.00
Jun 30, 2025 2.73 Mn
Mar 31, 2025 500.00
Dec 31, 2024 1.30 Mn
Sep 30, 2024 263,248.00
Jun 30, 2024 20,000.00
Mar 31, 2024 885,683.00
Dec 31, 2023 87,079.00
Sep 30, 2023 187,500.00
Jun 30, 2023 159,000.00
Mar 31, 2023 187,500.00
Dec 31, 2022 452,686.00
Sep 30, 2022 187,500.00
Jun 30, 2022 11.10 Mn
Mar 31, 2022 187,500.00
Dec 31, 2021 6.36 Mn
Sep 30, 2021 6.36 Mn
Jun 30, 2021 6.36 Mn
Mar 31, 2021 6.36 Mn
Dec 31, 2020 6.35 Mn